Ginkgo Bioworks Holdings, Inc.
DNA- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001830214
In the last 90 days, Ginkgo Bioworks Holdings, Inc. insiders filed 0 open-market purchases and 6 sales; 182 institutions reported holding it in 13F filings for Q3 2026, worth $494.5M in total; Viking Global Investors is the only superinvestor holding it.
Key figures
- Market capNo recent share count in SEC filings
- –
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $962.5K in total
- 6
- 13F holdersQ3 2026, +1 vs. previous quarter
- 182
- 13F valueReported value at the end of Q3 2026
- $494.5M
- Superinvestors holdingAt the end of Q3 2026
- 1
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $170.2M
- −25.1% year over year
- Net income, FY2025
- -$312.8M
- No comparable prior period
- Free cash flow, FY2025
- -$178.7M
- No comparable prior period
- Revenue, Q3 FY2026
- $27.7M
- −28.6% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $312.8M (183.8% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 9.49M
- Shares sold short
- Change
- +1.20M
- +14.4% vs. previous
- Days to cover
- 3.85
- At average daily volume
Superinvestors holding DNA, Q3 2026
Go to the superinvestors tab1 superinvestor reports holding Ginkgo Bioworks Holdings, Inc. on Form 13F. Percentages are the stock's share of each portfolio.
Viking Global Investors
Andreas Halvorsen
0.1%
Ginkgo Bioworks Holdings, Inc.'s share of the portfolio
- Shares
- 2,900,025
- Value
- $37.2M
Latest insider trades
See all insider tradesOpen-market purchases and sales by Ginkgo Bioworks Holdings, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 21, 2026 (view filing)4:07 PM ET | Oct 19 | 2 days | Coen Steven P.See remarks | SSaleClass A Common Stock | −766 | $10.14 | −$7.77K | −1.5%50.2K after | |
| Oct 21, 2026 (view filing)4:06 PM ET | Oct 19 | 2 days | Canton Barry10% Owner | SSaleClass A Common Stock | −18.8K | $10.14 | −$190.7K | −5.0%356.3K after | Duplicate filing |
| Oct 21, 2026 (view filing)4:06 PM ET | Oct 19 | 2 days | Canton Barry10% Owner | SSaleClass A Common Stock | −22.4K | $10.14 | −$226.9K | −4.7%454.0K after | Duplicate filing |
| Oct 21, 2026 (view filing)4:06 PM ET | Oct 19 | 2 days | Shetty Reshma P.See remarks | SSaleClass A Common Stock | −22.4K | $10.14 | −$226.9K | −4.7%454.0K after | |
| Oct 21, 2026 (view filing)4:06 PM ET | Oct 19 | 2 days | Shetty Reshma P.See remarks | SSaleClass A Common Stock | −18.8K | $10.14 | −$190.7K | −5.0%356.3K after | |
| Oct 21, 2026 (view filing)4:05 PM ET | Oct 19 | 2 days | Kelly Jason RSee remarks | SSaleClass A Common Stock | −45.7K | $10.14 | −$463.4K | −26.1%129.1K after | |
| Oct 7, 2026 (view filing)5:00 PM ET | Oct 5 | 2 days | Coen Steven P.See remarks | SSaleClass A Common Stock | −2.40K | $15.00 | −$36.0K | −4.6%49.4K after | |
| Sep 16, 2026 (view filing)4:06 PM ET | Sep 15 | 1 day | Henry Christian ODirector | SSaleClass A Common Stock | −5.00K | $7.08 | −$35.4K | −20.6%19.3K after | |
| Aug 25, 2026 (view filing)5:01 PM ET | Aug 24 | 1 day | Coen Steven P.See remarks | SSaleClass A Common Stock | −330 | $6.98 | −$2.30K | −0.6%51.9K after | |
| Jul 20, 2026 (view filing)5:00 PM ET | Jul 17 | 3 days | Coen Steven P.See remarks | SSaleClass A Common Stock | −752 | $7.90 | −$5.94K | −1.4%51.4K after |
Top 10 13F holders, Q3 2026
See all 182 holdersThe largest institutional positions in Ginkgo Bioworks Holdings, Inc. at the end of Q3 2026; share changes are against Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 4,519,135 | $58.0M | 0.00% | +236,232+5.5% | Added |
| Viking Global Investors LPSuperinvestorViking Global Investors | 2,900,025 | $37.2M | 0.11% | −677,103−18.9% | Reduced |
| Baillie Gifford & Co | 2,391,649 | $30.7M | 0.03% | 00.0% | Unchanged |
| Erste Asset Management GmbH | 2,536,939 | $30.3M | 0.22% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 2,109,962 | $27.1M | 0.00% | +22,669+1.1% | Added |
| Legal & General Group Plc | 1,812,398 | $23.3M | 0.00% | +142,979+8.6% | Added |
| Anchorage Capital Group, L.L.C. | 1,746,363 | $22.4M | 5.00% | 00.0% | Unchanged |
| State Street Corp | 1,568,735 | $20.1M | 0.00% | +96,365+6.5% | Added |
| Vanguard Portfolio Management LLC | 1,457,573 | $18.7M | 0.00% | +519,770+55.4% | Added |
| Geode Capital Management, LLC | 1,278,332 | $16.4M | 0.00% | +56,316+4.6% | Added |
Holders of 5% or more of DNA
See all 5 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Ginkgo Bioworks Holdings, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Shetty Reshma P. | 13D/A | 9.50%4.72M shares | – | Sep 27, 20215 filings | Feb 14, 2025 | SEC |
| BlackRock, Inc. | 13G/A | 7.70%4.12M shares | +1.20 ppfrom 6.50% | Jul 17, 20252 filings | Jul 30, 2026 | SEC |
| Cascade Investment, L.L.C. | 13G/A | 6.20%3.32M shares | −1.30 ppfrom 7.50% | Sep 24, 20213 filings | Nov 16, 2026 | SEC |
| Viking Global Investors LPSuperinvestorViking Global Investors | 13G/A | 5.40%2.90M shares | −1.70 ppfrom 7.10% | Sep 27, 20219 filings | Nov 16, 2026 | SEC |
| Che Austin | 13G/A | 5.00%2.37M shares | – | Sep 27, 20215 filings | Feb 14, 2025 | SEC |